Approval · Notice of Compliance 3874 · 1997
ROFERON-A: Notice of Compliance 3874
Issued September 2, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3874
- Date
- September 2, 1997
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New presentation: pre-filled syringes for self-administration
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROFERON-A | 02232975 | — |
| ROFERON-A | Not yet assigned | — |
Medicinal ingredients
- INTERFERON ALPHA-2A 3 UNIT per 0.5ML
- INTERFERON ALPHA-2A 4.5 M per 0.5ML
- INTERFERON ALPHA-2A 6 M per 0.5ML
- INTERFERON ALPHA-2A 9 M per 0.5ML